Health1 min read

STAT+: Pharmalittle: We’re reading about Lilly conflict questions, a DEA OK for a narcolepsy pill, and more

By · Via STAT Health · Published by Everything Blog

In short

Takeda has officially launched its narcolepsy pill, Orzeyful, in the United States following the Drug Enforcement Administration's decision to classify it as a Schedule IV controlled substance. The therapy, priced at $16,500 for a 60-tablet bottle, is the first to directly address the underlying mechanism of the condition for roughly 120,000 affected Americans. Concurrently, Pfizer is halting sales of all Premarin tablets and creams in Canada following an internal evaluation, worsening existing shortages across the country. This withdrawal contrasts with rising broader demand for hormone replacement therapies, which accelerated in the United States after safety warnings were lifted last yea…

Key points

  • Narcolepsy patients in the United States now have access to the first therapy engineered…: Narcolepsy patients in the United States now have access to the first therapy engineered to treat the core cause of the sleep disorder.
  • Canadian patients face worsening menopause therapy constraints after Pfizer permanently d…: Canadian patients face worsening menopause therapy constraints after Pfizer permanently discontinued the Premarin product line.
  • Demand for menopausal hormone treatments continues to climb across North America followin…: Demand for menopausal hormone treatments continues to climb across North America following the removal of previous federal safety warnings.

Sources checked by our analysis pipeline: 1

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, so far, rather modest. We plan to tidy the Pharmalot grounds, catch up on our reading, promenade with the official mascots, and of course, hold a listening party with Mrs. Pharmalot. So far, the rotation will include this, this, this, this, and this. And what about you? This may be an opportunity to tend to the grounds. You could take a long walk in a park or wander about city streets. Holidays are approaching so perhaps this an opportunity to go shopping and boost the economy. Or you could be zen for a while, relax your mind and do absolutely nothing. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon.…

Takeda reported that its narcolepsy pill, the first treatment to target the underlying cause of the rare sleep disorder, is now available in the U.S. after the U.S. Drug Enforcement…

Health